Kratos: Strong Demand but Cash Burn and Delayed Valkyrie Ramp Cap the Upside

What happened

Kratos Defense posted a solid Q1: revenue up 23% to $371M, a record $2B backlog, and a 1.6x book-to-bill, prompting a strong-buy upgrade after a 50% stock decline. The news highlights hypersonics, Valkyrie drones, and directed energy as key growth drivers. However, the latest filings confirm that Valkyrie rate readiness is anchored to end-2027 and that investments to scale production are pressuring margins and free cash flow through FY27. With free cash flow still negative (-$27.4M operating cash flow in Q1) and the stock trading at 92x EV/EBITDA, the near-term demand strength is priced in, while the consumption of cash and delayed timeline leave little room for error. The gap between the bullish narrative and filing-based execution realities keeps the risk-reward unfavorable until funded backlog growth and cash conversion improve.

Implication

The strong Q1 and elevated backlog confirm demand, but Kratos remains a show-me story. The path to value creation requires funded backlog to rise from $1.46B and operating cash flow to turn positive as inventory growth moderates. Until those tangible signs emerge, the 92x EV/EBITDA multiple is vulnerable to compression. Position sizing must reflect that the thesis relies on execution milestones through end-2027, not current earnings. The Feb. 2026 equity raise funds the ramp but dilutes per-share outcomes; investors should only add after at least two consecutive quarters of funded backlog growth and sequential FCF improvement.

Thesis delta

The upgrade-driven bullish narrative is partially validated by strong Q1 bookings/backlog, but the filings expose a slower Valkyrie ramp (end-2027) and persistent cash burn that contradict the market's near-term scaling expectations. The thesis shifts from 'buy the growth story' to 'wait for funded backlog growth and cash conversion'—no change in our WAIT rating until those metrics improve.